Jason C. Jones - 31 Aug 2022 Form 4 Insider Report for EKSO BIONICS HOLDINGS, INC. (EKSO)

Role
Senior VP Product Development
Signature
/s/ Jerome Wong, as Attorney-in-Fact
Issuer symbol
EKSO
Transactions as of
31 Aug 2022
Transactions value $
-$13,587
Form type
4
Filing time
02 Sep 2022, 17:50:49 UTC
Previous filing
11 Apr 2022
Next filing
17 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EKSO Common Stock Sale -$13.6K -5.87K -4.46% $2.31 126K 31 Aug 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold by the Reporting Person on August 31, 2022 to cover tax withholding obligations incurred upon the vesting and settlement of the first installment of a restricted stock award originally reported by the Reporting Person in Form 4 filed with the Commission on April 11, 2022
F2 The sale price represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $2.31 to $2.32, inclusive. The Company can provide the full information regarding the number of shares sold at each separate price upon further request.